Several novel substances are receiving attention within the biomedical field. Retatrutide, a double GLP-1 and GIP agonist, is demonstrating efficacy for obesity management. BPC-157, or Body Protecting Fragment 157, is https://ghk-cu020543.wikiinside.com/4545919/retatrutide_bpc_157_ghk_cu_tb_500_a_deep_dive_into_emerging_compounds